Additionally, immunohistochemical staining from human samples revealed that hepatic PTPRO was reduced in livers from subjects with NAFLD compared to subjects with normal livers, while p62/SQSTM1 was increased [137,150]. Here, SQSTM1 is linked to metabolic dysfunction-associated steatotic liver disease.